Title |
The role of melatonin in diabetes: therapeutic implications
|
---|---|
Published in |
Archives of Endocrinology and Metabolism, August 2015
|
DOI | 10.1590/2359-3997000000098 |
Pubmed ID | |
Authors |
Shweta Sharma, Hemant Singh, Nabeel Ahmad, Priyanka Mishra, Archana Tiwari |
Abstract |
Melatonin referred as the hormone of darkness is mainly secreted by pineal gland, its levels being elevated during night and low during the day. The effects of melatonin on insulin secretion are mediated through the melatonin receptors (MT1 and MT2). It decreases insulin secretion by inhibiting cAMP and cGMP pathways but activates the phospholipaseC/IP3 pathway, which mobilizes Ca2+from organelles and, consequently increases insulin secretion. Both in vivo and in vitro, insulin secretion by the pancreatic islets in a circadian manner, is due to the melatonin action on the melatonin receptors inducing a phase shift in the cells. Melatonin may be involved in the genesis of diabetes as a reduction in melatonin levels and a functional interrelationship between melatonin and insulin was observed in diabetic patients. Evidences from experimental studies proved that melatonin induces production of insulin growth factor and promotes insulin receptor tyrosine phosphorylation. The disturbance of internal circadian system induces glucose intolerance and insulin resistance, which could be restored by melatonin supplementation. Therefore, the presence of melatonin receptors on human pancreatic islets may have an impact on pharmacotherapy of type 2 diabetes. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 7% |
Canada | 2 | 7% |
United States | 2 | 7% |
Germany | 1 | 3% |
Czechia | 1 | 3% |
India | 1 | 3% |
Unknown | 20 | 69% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 19 | 66% |
Practitioners (doctors, other healthcare professionals) | 10 | 34% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Russia | 1 | <1% |
Unknown | 155 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 29 | 18% |
Student > Master | 19 | 12% |
Student > Ph. D. Student | 13 | 8% |
Student > Postgraduate | 12 | 8% |
Researcher | 10 | 6% |
Other | 26 | 16% |
Unknown | 49 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 29 | 18% |
Agricultural and Biological Sciences | 22 | 14% |
Medicine and Dentistry | 18 | 11% |
Nursing and Health Professions | 10 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
Other | 15 | 9% |
Unknown | 58 | 37% |